top of page
Our Mission
At de facto diagnostics, we strive to redefine the standard of transplant care. Through rigorous scientific inquiry and clinical precision, our mission is to deliver high-fidelity diagnostic products that empower medical professionals with the absolute clarity required for life-saving decision making.
Dr. Sarah Chen
Chief Executive Officer
Dr. Chen leads our strategic vision with over fifteen years of expertise in clinical pathology and diagnostic development.
Dr. Marcus Thorne
Chief Scientific Officer
Dr. Thorne oversees our research initiatives, pioneering precision-engineered products that transform transplant diagnostics.
bottom of page